As global dynamics reshape local healthcare realities, go-to-market strategies for new medicines are entering a new era – one that calls for greater agility, collaboration, and strategic leadership.

Evolving approaches to pricing, access, and reimbursement are influencing how companies evaluate assets, prioritize launches, and bring innovation to patients. At the same time, these shifts are creating new opportunities to rethink commercial strategy and strengthen cross-functional alignment.

Commercialization teams have an increasingly important role to play in helping organizations adapt with confidence – bringing clarity to complexity, shaping strategic direction, and ensuring patient and business needs remain aligned.

Building on the keynote address, this panel of commercial leaders will share insights into how organizations can position themselves for success in a rapidly evolving environment.